Ikarian Capital, LLC - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 1 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$93,359
-18.1%
237,5530.0%0.02%
-25.0%
Q4 2022$114,026
-71.3%
237,5530.0%0.03%
-64.6%
Q3 2022$397,000
-57.7%
237,553
-28.1%
0.08%
-53.8%
Q2 2022$938,000
-43.6%
330,5230.0%0.17%
-21.9%
Q1 2022$1,662,000
-47.2%
330,523
+4.7%
0.22%
-53.3%
Q4 2021$3,148,000
-23.3%
315,7320.0%0.47%
+62.3%
Q3 2021$4,106,000
-10.2%
315,732
-2.9%
0.29%
-21.9%
Q2 2021$4,573,000
+91.6%
325,000
+116.7%
0.37%
+362.5%
Q1 2021$2,387,000150,0000.08%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q2 2023
NameSharesValueWeighting ↓
TRB Advisors LP 550,000$7,739,0001.75%
Bleichroeder LP 810,416$11,403,0001.72%
Aperture Investors, LLC 319,122$4,490,0000.51%
Ikarian Capital, LLC 325,000$4,573,0000.37%
SECTORAL ASSET MANAGEMENT INC 300,399$4,227,0000.34%
Baupost Group 1,208,159$16,693,0000.14%
Proficio Capital Partners LLC 112,059$1,577,0000.12%
LIGHT STREET CAPITAL MANAGEMENT, LLC 168,330$2,368,0000.10%
MSD Partners, L.P. 235,294$3,311,0000.09%
PURA VIDA INVESTMENTS, LLC 71,552$1,007,0000.03%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders